Disc Medicine, Inc. (IRON) Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a clinical-stage biotechnology company. Its core mission involves the discovery, development, and commercialization of novel therapeutic solutions for individuals suffering from serious hematological diseases. The company is actively constructing a pipeline of drug candidates, designed to address a variety of these conditions by precisely targeting fundamental biological mechanisms related to red blood cell biology, particularly heme biosynthesis and iron homeostasis.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Disc Medicine, Inc. NASDAQ:IRON Healthcare · Biotechnology
AH Close $74.83 +0.43%vs close AH Close $74.83 +0.43% vs close
8-K 8-K/A 10-K 10-Q S-1 S-1/A S-3 S-3ASR S-4 S-4/A S-8 DEF 14A DEFA14A 3 3/A 4 4/A 13D 13D/A 13G 13G/A 144 424B3 424B4 424B5 UPLOAD CORRESP 425
Form Description Filed Links 8-K 10/22/26 Oct 22, 2026 4 Statement of Changes in Beneficial Ownership
10/21/26 Oct 21, 2026 424B5 10/21/26 Oct 21, 2026 144 Notice of Proposed Sale of Securities
10/21/26 Oct 21, 2026 144 Notice of Proposed Sale of Securities
10/21/26 Oct 21, 2026 144 Notice of Proposed Sale of Securities
10/21/26 Oct 21, 2026 144 Notice of Proposed Sale of Securities
10/21/26 Oct 21, 2026 144 Notice of Proposed Sale of Securities
10/20/26 Oct 20, 2026 144 Notice of Proposed Sale of Securities
10/20/26 Oct 20, 2026 144 Notice of Proposed Sale of Securities
10/20/26 Oct 20, 2026 144 Notice of Proposed Sale of Securities
10/20/26 Oct 20, 2026 424B5 10/20/26 Oct 20, 2026 144 Notice of Proposed Sale of Securities
10/19/26 Oct 19, 2026 144 Notice of Proposed Sale of Securities
10/19/26 Oct 19, 2026 144 Notice of Proposed Sale of Securities
10/19/26 Oct 19, 2026 144 Notice of Proposed Sale of Securities
10/19/26 Oct 19, 2026 8-K 10/19/26 Oct 19, 2026 4 Statement of Changes in Beneficial Ownership
9/16/26 Sep 16, 2026 4 Statement of Changes in Beneficial Ownership
9/15/26 Sep 15, 2026 144 Notice of Proposed Sale of Securities
9/11/26 Sep 11, 2026 8-K 9/10/26 Sep 10, 2026 4 Statement of Changes in Beneficial Ownership
9/9/26 Sep 9, 2026 144 Notice of Proposed Sale of Securities
9/4/26 Sep 4, 2026 144 Notice of Proposed Sale of Securities
9/4/26 Sep 4, 2026 144 Notice of Proposed Sale of Securities
9/4/26 Sep 4, 2026